New survey asks: how attractive is the UK to global pharma and biotech?
By World Healthcare Journal-
Life sciences and pharma experts from across the globe have been asked to share their thoughts on how the UK's departure from the EU and impact of Covid-19 effects the UK's standing as an innovation hub.
In light of the UK’s departure from the European Union and the impact of the Covid-19 pandemic, IQVIA (a world leader in healthcare data, technology, advanced analytics and expertise) has commissioned Informa Pharma Intelligence (who provide precision and forward-focused analysis into the pharma sector) to conduct research on the overall attractiveness of the UK Life Sciences ecosystem to the global pharmaceutical and biotech industry.
In particular, this survey focuses on the global Life Sciences sector’s current and future appetite for investing in clinical research and launching medicines within the UK. This work is in collaboration with Public Policy Projects (PPP), and will be shared at a PPP event later in the year.
Respondents the survey will be entered in a draw to win one of four €/$/£100 Amazon gift vouchers.
To participate in the survey, click here.
#whj #whjIQVIA #whjnews #IQVIA #PPPIQVIA #PPPnews